putting the population health at risk. However, there is a dearth in knowledge about how the Australian public health system will address the impacts of climate change.
Acyclic nucleoside and nucleotide analogues are a large class of antivirals that have been licenced for the treatment of HSV-1 and HSV-2 infections [40,41]. These antivirals prevent viral DNA polymerase from extending the viral genome during replication (UL30). ACV is the most common first-...